Top Markets
Coin of the day
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Clasificación en acciones #29651
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Precio por acción
$0.68377137
Última sincronización: 2023-05-23
Capitalización bursátil
$20.23M
Cambio (1 día)
-0.60%
Cambio (1 año)
0.00%
País
SE
Comercio Medivir AB (publ) (MVIR-B)

Categoría

Historial de desdoblamientos de acciones de Medivir AB (publ) (MVIR-B)
La acción Medivir AB (publ) (símbolo: MVIR-B) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 19, 2026.
Una acción MVIR-B comprada antes de Aug 19, 2026 equivaldría hoy a 0 acciones MVIR-B.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR